Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk
Genes & Cancer · 01.11.2013 · 4 (11-12) · 427-446
DOI: 10.1177/1947601913503341 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes & Cancer, online erschienen am 19.09.2013. Verfasst von Indranil Paul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Signal Transduction in Cancer and Stem Cells Laboratory, Cancer Biology and Inflammatory Disorder Division, Indian Institute of Chemical Biology, Kol…. Die Arbeit wurde bisher 140-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Glioblastoma multiformes (GBMs) are extensively heterogeneous at both cellular and molecular levels. Current therapeutic strategies include targeting of key signaling molecules using pharmacological inhibitors in combination with genotoxic agents such as temozolomide. In spite of all efforts, the prognosis of glioma patients remains dismal. Therefore, a proper understanding of individual molecular pathways responsible for the progression of GBM is necessary. The epidermal growth factor receptor (EGFR) pathway is probably the most significant signaling pathway clinically implicated in glioma. Not surprisingly, anti-EGFR therapies mostly prevail for therapeutic purposes. The Wnt/β-catenin pathway is well implicated in multiple tumors; however, its role in glioma has only recently started to emerge. We give a concise account of the current understanding of the role of both these pathways in glioma. Last, taking evidences from a limited literature, we outline a number of points where these pathways intersect each other and put forward the possibility of combinatorially targeting them for treatment of glioma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Signal Transduction in Cancer and Stem Cells Laboratory, Cancer Biology and Inflammatory Disorder Division, Indian Institute of Chemical Biology, Kolkata, India.
Zitieren
APA
Paul, I., Bhattacharya, S., Chatterjee, A., & Ghosh, M. K. (2013). Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk. Genes & Cancer, 4(11-12), 427-446. https://doi.org/10.1177/1947601913503341
Vancouver
Paul I, Bhattacharya S, Chatterjee A, Ghosh MK. Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk. Genes & Cancer. 2013;4(11-12):427-446. doi:10.1177/1947601913503341
BibTeX
@article{Paul2013,
author = {Paul, Indranil and Bhattacharya, Seemana and Chatterjee, Anirban and Ghosh, Mrinal K},
title = {Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk},
journal = {Genes & Cancer},
year = {2013},
volume = {4},
number = {11-12},
pages = {427--446},
doi = {10.1177/1947601913503341}
}
EUVIMED